Ceramide in apoptotic signaling and anticancer therapy

C. F. Lin, Chia-Ling Chen, Yee-Shin Lin

研究成果: 雜誌貢獻文章

62 引文 (Scopus)

摘要

Ceramide, a product of sphingolipid metabolism, is generated in response to various stress stimuli, such as tumor necrosis factor-α, CD95 /Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. It is believed that the biological effect of ceramide depends on its concentration, the activation or differentiation status of the cell, and the time frame of action. Here, we discuss the metabolism and cell apoptotic signaling of ceramide. The involvement of protein kinases (i.e. P13K/Akt and GSK-3β) and protein phosphatases (i.e. PP1 and PP2A), Bcl-2 family proteins, mitochondrial damage, and caspase cascade activation are demonstrated. Further, ceramide and its derivatives have recently been incorporated into strategies for anticancer therapies. An understanding of the apoptotic signaling pathways mediated by ceramide may shed light on its potential for therapeutic intervention.
原文英語
頁(從 - 到)1609-1616
頁數8
期刊Current Medicinal Chemistry
13
發行號14
DOIs
出版狀態已發佈 - 六月 2006

指紋

Ceramides
Metabolism
Therapeutics
Biochemical Phenomena
Chemical activation
Cell signaling
Glycogen Synthase Kinase 3
Sphingolipids
Phosphoprotein Phosphatases
Mitochondrial Proteins
Caspases
Protein Kinases
Cell Differentiation
Tumor Necrosis Factor-alpha
Irradiation
Apoptosis
Derivatives

ASJC Scopus subject areas

  • Organic Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Pharmacology

引用此文

Ceramide in apoptotic signaling and anticancer therapy. / Lin, C. F.; Chen, Chia-Ling; Lin, Yee-Shin.

於: Current Medicinal Chemistry, 卷 13, 編號 14, 06.2006, p. 1609-1616.

研究成果: 雜誌貢獻文章

@article{a538f9f566154779bacf6e6db03a6f14,
title = "Ceramide in apoptotic signaling and anticancer therapy",
abstract = "Ceramide, a product of sphingolipid metabolism, is generated in response to various stress stimuli, such as tumor necrosis factor-α, CD95 /Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. It is believed that the biological effect of ceramide depends on its concentration, the activation or differentiation status of the cell, and the time frame of action. Here, we discuss the metabolism and cell apoptotic signaling of ceramide. The involvement of protein kinases (i.e. P13K/Akt and GSK-3β) and protein phosphatases (i.e. PP1 and PP2A), Bcl-2 family proteins, mitochondrial damage, and caspase cascade activation are demonstrated. Further, ceramide and its derivatives have recently been incorporated into strategies for anticancer therapies. An understanding of the apoptotic signaling pathways mediated by ceramide may shed light on its potential for therapeutic intervention.",
keywords = "Anticancer, Apoptosis, Caspase, Ceramide, Mitochondria, Protein kinase, Protein phosphatase, Sphingolipid",
author = "Lin, {C. F.} and Chia-Ling Chen and Yee-Shin Lin",
year = "2006",
month = "6",
doi = "10.2174/092986706777441986",
language = "English",
volume = "13",
pages = "1609--1616",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "14",

}

TY - JOUR

T1 - Ceramide in apoptotic signaling and anticancer therapy

AU - Lin, C. F.

AU - Chen, Chia-Ling

AU - Lin, Yee-Shin

PY - 2006/6

Y1 - 2006/6

N2 - Ceramide, a product of sphingolipid metabolism, is generated in response to various stress stimuli, such as tumor necrosis factor-α, CD95 /Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. It is believed that the biological effect of ceramide depends on its concentration, the activation or differentiation status of the cell, and the time frame of action. Here, we discuss the metabolism and cell apoptotic signaling of ceramide. The involvement of protein kinases (i.e. P13K/Akt and GSK-3β) and protein phosphatases (i.e. PP1 and PP2A), Bcl-2 family proteins, mitochondrial damage, and caspase cascade activation are demonstrated. Further, ceramide and its derivatives have recently been incorporated into strategies for anticancer therapies. An understanding of the apoptotic signaling pathways mediated by ceramide may shed light on its potential for therapeutic intervention.

AB - Ceramide, a product of sphingolipid metabolism, is generated in response to various stress stimuli, such as tumor necrosis factor-α, CD95 /Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. It is believed that the biological effect of ceramide depends on its concentration, the activation or differentiation status of the cell, and the time frame of action. Here, we discuss the metabolism and cell apoptotic signaling of ceramide. The involvement of protein kinases (i.e. P13K/Akt and GSK-3β) and protein phosphatases (i.e. PP1 and PP2A), Bcl-2 family proteins, mitochondrial damage, and caspase cascade activation are demonstrated. Further, ceramide and its derivatives have recently been incorporated into strategies for anticancer therapies. An understanding of the apoptotic signaling pathways mediated by ceramide may shed light on its potential for therapeutic intervention.

KW - Anticancer

KW - Apoptosis

KW - Caspase

KW - Ceramide

KW - Mitochondria

KW - Protein kinase

KW - Protein phosphatase

KW - Sphingolipid

UR - http://www.scopus.com/inward/record.url?scp=33744749249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744749249&partnerID=8YFLogxK

U2 - 10.2174/092986706777441986

DO - 10.2174/092986706777441986

M3 - Article

C2 - 16787207

AN - SCOPUS:33744749249

VL - 13

SP - 1609

EP - 1616

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 14

ER -